INTRODUCTION: Argentina has a large number of patients with definite diagnosis of X-linked agammaglobulinemia reported in the Latin-American registry. Forty-nine of them were seen in our referral pediatric hospital, between 1987 and 2005. RESULTS AND DISCUSSION: A retrospective study of clinical, laboratory, and molecular data showed that respiratory tract infections were the most frequent initial clinical presentation and the most common among all manifestations prior to diagnosis (69%). Up to diagnosis, we found a high frequency of severe infections (sepsis, 14% and meningitis, 16%) and a high proportion of patients with chronic lung disease. During follow-up, the development of chronic lung disease was significantly related with age at diagnosis and inappropriate treatment. CONCLUSION: Although molecular diagnosis has been available in our center for the past 10 years, there is no doubt that awareness for early recognition of immunodeficiency should be improved through broader and more comprehensive education programs emphasizing characteristics of patients with immunodeficiencies.
INTRODUCTION: Argentina has a large number of patients with definite diagnosis of X-linked agammaglobulinemia reported in the Latin-American registry. Forty-nine of them were seen in our referral pediatric hospital, between 1987 and 2005. RESULTS AND DISCUSSION: A retrospective study of clinical, laboratory, and molecular data showed that respiratory tract infections were the most frequent initial clinical presentation and the most common among all manifestations prior to diagnosis (69%). Up to diagnosis, we found a high frequency of severe infections (sepsis, 14% and meningitis, 16%) and a high proportion of patients with chronic lung disease. During follow-up, the development of chronic lung disease was significantly related with age at diagnosis and inappropriate treatment. CONCLUSION: Although molecular diagnosis has been available in our center for the past 10 years, there is no doubt that awareness for early recognition of immunodeficiency should be improved through broader and more comprehensive education programs emphasizing characteristics of patients with immunodeficiencies.
Authors: Jessica M Lindvall; K Emelie M Blomberg; Jouni Väliaho; Leonardo Vargas; Juhana E Heinonen; Anna Berglöf; Abdalla J Mohamed; Beston F Nore; Mauno Vihinen; C I Edvard Smith Journal: Immunol Rev Date: 2005-02 Impact factor: 12.988
Authors: K Nomura; H Kanegane; H Karasuyama; S Tsukada; K Agematsu; G Murakami; S Sakazume; M Sako; R Tanaka; Y Kuniya; T Komeno; S Ishihara; K Hayashi; T Kishimoto; T Miyawaki Journal: Blood Date: 2000-07-15 Impact factor: 22.113
Authors: D Vetrie; I Vorechovský; P Sideras; J Holland; A Davies; F Flinter; L Hammarström; C Kinnon; R Levinsky; M Bobrow Journal: Nature Date: 1993-01-21 Impact factor: 49.962
Authors: S Tsukada; D C Saffran; D J Rawlings; O Parolini; R C Allen; I Klisak; R S Sparkes; H Kubagawa; T Mohandas; S Quan Journal: Cell Date: 1993-01-29 Impact factor: 41.582
Authors: Sandra Lorena Colli; Nazarena Cardoso; Carla Antonella Massone; María Cores; Mercedes García Lombardi; Elena Noemí De Matteo; Mario Alejandro Lorenzetti; María Victoria Preciado Journal: PLoS One Date: 2022-04-01 Impact factor: 3.240
Authors: Jacques G Rivière; Clara Franco-Jarava; Mónica Martínez-Gallo; Aina Aguiló-Cucurull; Laura Blasco-Pérez; Ida Paramonov; María Antolín; Andrea Martín-Nalda; Pere Soler-Palacín; Roger Colobran Journal: Front Immunol Date: 2020-02-12 Impact factor: 7.561